Tower Research Capital (TRC)’s Windtree Therapeutics WINT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.14K | Buy |
2,212
+836
| +61% | +$432 | ﹤0.01% | 4867 |
|
2025
Q1 | $1.73K | Buy |
1,376
+1,286
| +1,429% | +$1.62K | ﹤0.01% | 4657 |
|
2024
Q4 | $1.58K | Buy |
90
+51
| +131% | +$894 | ﹤0.01% | 4998 |
|
2024
Q3 | $4.64K | Buy |
39
+9
| +30% | +$1.07K | ﹤0.01% | 4465 |
|
2024
Q2 | $4.83K | Buy |
+30
| New | +$4.83K | ﹤0.01% | 4741 |
|
2023
Q4 | – | Sell |
-11
| Closed | -$9.18K | – | 6198 |
|
2023
Q3 | $9.18K | Buy |
11
+3
| +38% | +$2.5K | ﹤0.01% | 4252 |
|
2023
Q2 | $9.03K | Buy |
8
+7
| +700% | +$7.9K | ﹤0.01% | 4317 |
|
2023
Q1 | $6K | Buy |
+1
| New | +$6K | ﹤0.01% | 4890 |
|
2022
Q4 | – | Hold |
0
| – | -$6K | – | 5246 |
|
2022
Q3 | – | Sell |
-1
| Closed | -$12K | – | 5071 |
|
2022
Q2 | $12K | Buy |
+1
| New | +$12K | ﹤0.01% | 4321 |
|
2022
Q1 | – | Hold |
0
| – | -$1K | – | 5120 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 5896 |
|
2021
Q3 | – | Sell |
-1
| Closed | -$62K | – | 6225 |
|
2021
Q2 | $62K | Buy |
+1
| New | +$62K | ﹤0.01% | 2843 |
|
2021
Q1 | – | Hold |
0
| – | -$19K | – | 5770 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 3908 |
|